Home > Drug Search >
  • company_query: Aldeyra Therapeutics
  •   > 
Drug Filter
Category:
chemistry (23) biology (4)
Status:
Approved (2) NDA Filing (3) BLA Filing (2) Phase Ⅲ (4) Phase Ⅱ (7) Phase Ⅰ (9)
Clinical Stage:
Pending (3) Active (20) Discontinued (2)
Bio-Type:
Vaccine (1) Recombinant enzyme (2) Whole antibody (1)
Indication:
Allergic rhinitis (AR) (1) Asthma (1) Atrial fibrillation (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Cutaneous T cell lymphoma (CTCL) (1) Depression (1) Epilepsy/Seizures (1) HBV infection (1) HIV infection (1) Lung cancer (1) Melanoma (2) Non small cell lung cancer (NSCLC) (2) Non-Hodgkin B-cell lymphomas (1) Osteoarthritis (OA) (2) Pancreatic cancer (1) Postoperative pain (1) Primary hypertension (1) Pulmonary arterial hypertension (1) Rheumatoid arthritis (RA) (2) Solid tumours (2) Type 2 diabetes (1) Uveitis (1) Ankylosing Spondylitis (AS) (1) Shoulder periarthritis (1) Colon cancer (1) Neuroblastoma (1) Metastatic non-small cell lung cancer (1) Waldenström's macroglobulinemia (WM) (1) B-cell lymphoma (1) HER2-positive metastatic breast cancer (1) Spinocerebellar ataxia (1) Oculopharyngeal muscular dystrophy (1) Fatty aldehyde dehydrogenase deficiency (1) Opioid dependency (1) Mucopolysaccharidosis VII (Sly syndrome) (2) Hereditary inclusion body myopathy (HIBM) (1) Fatty acid oxidation disorders (1) Glucose transporter type 1 deficiency syndrome (1) Esophagus cancer (1) Gout (1) Diffuse large B cell lymphoma (1) Ebola virus disease (EVD) (1) X-linked hypophosphatemia (1) Inflammatory pain (1)
Country:
Aprv. Year:
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top